U.S. Electric Utilities Stock News

NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

Is StoneCo (STNE) Now An Opportunity After Recent Share Price Slide?

This article examines whether StoneCo, trading at around US$10.98, could be considered a bargain or a value trap by focusing on what the current share price might imply about the company. The stock has experienced significant recent volatility, with a 24.5% decline over the last week, a 22.2% decline over the last month, and a 25.3% decline year to date. Over longer periods, the 1 year return shows a 4.3% decline and the 5 year return a 78.3% decline. Recent commentary around StoneCo has...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics ADA Data Could Reframe Oral Obesity And Diabetes Prospects

Structure Therapeutics (NasdaqGM:GPCR) plans multiple presentations at the 86th American Diabetes Association Scientific Sessions. The company will share new safety, efficacy, and dosing data for its oral GLP-1 receptor agonist aleniglipron. Additional data will cover a novel amylin receptor agonist combination, including findings on weight loss effects. The presentations focus on combination approaches in obesity and diabetes treatment development. Structure Therapeutics focuses on oral...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Is It Too Late To Consider Camtek (CAMT) After Its 191% One Year Surge

If you are wondering whether Camtek's current share price reflects its underlying value, you are not alone. That question is exactly what this article will help you think through. Camtek's stock has been volatile recently, with a 2% decline over the last week, a 26.6% gain over the last 30 days, a 66.2% return year to date, and a 191.3% return over the last year, along with very large multi year gains. These moves have put Camtek firmly on many investors' radars, and recent coverage has...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox’s Purell Deal Expands Health Focus As Earnings Outlook Softens

Clorox, NYSE:CLX, has completed its acquisition of GOJO Industries, the owner of the Purell brand. The deal adds a broad health and hygiene portfolio to Clorox's existing cleaning and household products. This transaction reflects a move to broaden Clorox's exposure beyond traditional household categories. Clorox enters this deal with its shares at $96.44, after a 27.3% decline over the past year and a 38.1% decline over the past five years. The acquisition of GOJO and Purell gives the...
NYSE:JOE
NYSE:JOEReal Estate

St. Joe (JOE) Q1 EPS Compression Tests Bullish Premium Multiple Narrative

St. Joe (JOE) opened 2026 with Q1 revenue of US$99 million and basic EPS of US$0.24, compared with Q1 2025 revenue of US$94 million and EPS of US$0.30. Trailing twelve month EPS stood at US$1.94 on revenue of US$518 million. Over that same twelve month stretch, net income reached US$112 million, giving investors a fuller view of how quarterly earnings feed into the broader profit picture. With a net margin of 21.6% over the last year, the latest numbers keep the spotlight firmly on how...
NYSE:MTH
NYSE:MTHConsumer Durables

Is Meritage Homes (MTH) Pricing Look Interesting After Recent Share Price Swings?

If you are wondering whether Meritage Homes at around US$67.34 is a bargain or just fairly priced, this breakdown will help you frame what the current share price might actually be offering you. The stock has recently been choppy, with a 3.7% decline over the last 7 days, an 8.9% gain over the past 30 days, and returns of 1.7% year to date and 3.2% over the last year. Recent coverage has focused on how Meritage Homes fits into the broader US homebuilding sector, with attention on its ability...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After Its 192% One-Year Surge?

If you are wondering whether Centessa Pharmaceuticals at around US$39.42 is still offering value after its surge, you are asking the right question for this stock. The share price has delivered a 66.4% return year to date and 192.0% over the last year, with the 3 year return described as very large, even though the last 30 days have seen a small 0.8% decline and the last week has been flat at 0.0%. Recent coverage has focused on Centessa Pharmaceuticals as a higher growth biotech name, and...
NYSE:UAA
NYSE:UAALuxury

Is Under Armour (UAA) Now Priced At A Discount After Recent Brand Reset Moves

If you are wondering whether Under Armour at US$6.29 is attractively priced or still a value trap, the starting point is understanding what the current market price actually implies about the business. The stock has returned 6.4% over the last 30 days and 18.9% year to date, while the 1 year return sits at 8.4% against a much weaker 3 year and 5 year record of 24.1% and 74.5% declines. Recent headlines have focused on how Under Armour is repositioning its brand and product lineup to stay...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP Results, Dividend And Buyback Highlight Capital Allocation And Ownership

XP Inc. (NasdaqGS:XP) released its audited 2025 annual results, giving investors a detailed view of the company’s most recent financial year. The company announced a new cash dividend, signaling a direct return of capital to shareholders. XP also launched a fresh share repurchase program and reported significant ownership positions held by institutional investors. XP operates as a financial services platform, connecting retail and institutional clients to investment products and advisory...
NYSE:NIQ
NYSE:NIQMedia

Is NIQ Global Intelligence (NIQ) Offering An Opportunity After This Year’s 30% Share Price Slide

This article considers whether NIQ Global Intelligence, at around US$10.93, offers value or simply appears cheap on the surface by examining what the current price might really imply. The share price has eased back recently, with a 7‑day return of a 2.6% decline, a 30‑day return of a 3.9% decline, and a year‑to‑date return of a 30.7% decline. Recent coverage has focused on the stock's weaker near‑term returns and what they might signal about investor expectations, which helps explain why...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Q3 Profit Challenges Bearish Narratives On Persistent Losses

Viavi Solutions (VIAV) just posted Q3 2026 results with revenue of US$406.8 million and basic EPS of US$0.03, while on a trailing twelve month basis revenue stands at US$1.4 billion with a basic EPS loss of US$0.24. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$406.8 million in Q3 2026, alongside basic EPS shifting from US$0.04 in Q2 2025 to US$0.03 in the latest quarter and swinging between profits and losses in the periods in between. This...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Net Margin Of 8.8% Tests Bullish Profit Expansion Narrative

ATI (ATI) has opened Q1 2026 earnings season with Q4 2025 revenue of US$1.2 billion and basic EPS of US$0.71, setting the stage against a current share price of US$155.46 as investors focus on how these results fit into the company’s recent earnings trajectory. Over the past year, quarterly revenue has ranged from US$1.1 billion to US$1.2 billion, while basic EPS has moved between US$0.64 and US$0.80. This provides a clear view of how the top and bottom line have tracked together across...
NYSE:CE
NYSE:CEChemicals

Is It Too Late To Consider Celanese (CE) After Its Strong Year To Date Rally

Investors may be wondering if Celanese is still attractively priced after its recent run, or if most of the value story is already reflected in the share price. The stock last closed at US$67.76, with returns of 3.9% over the past week, 3.0% over the past month, 60.7% year to date, and 49.6% over the past year, set against longer term returns of negative 30.6% over three years and negative 56.5% over five years. Recent coverage has focused on Celanese's position in the chemicals sector and...
NasdaqGS:BZ
NasdaqGS:BZProfessional Services

Kanzhun’s 2025 ESG Report Adds Context To Ongoing Share Price Weakness

Kanzhun Limited (NasdaqGS:BZ) has published its 2025 Environmental, Social and Governance report. The report outlines progress across sustainability, product responsibility, employee development, and corporate governance pillars. The disclosure adds fresh detail on how the company is approaching ESG priorities that have not been covered in recent updates. Kanzhun, trading at $13.52, has experienced pressure over longer periods, with the share price showing a 35.3% decline year to date and a...
NasdaqGS:SMCI
NasdaqGS:SMCITech

3 Growth Stocks With High Insider Ownership Achieving 19% Revenue Growth

Over the last 7 days, the United States market has remained flat, yet it is up 29% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying growth stocks with high insider ownership can be appealing as these companies often benefit from strong alignment between management and shareholders, potentially driving sustainable revenue growth.
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer Global And 2 Exciting Penny Stocks To Watch

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings forecasted to grow annually by 16%. While penny stocks might seem like a term from a bygone era, they still hold significant potential for investors looking to explore smaller or newer companies that boast strong financials. This article highlights three such penny stocks that could offer both affordability and growth opportunities in today's market landscape.
NasdaqGS:CCB
NasdaqGS:CCBBanks

Is It Time To Revisit Coastal Financial (CCB) After The Recent Share Price Pullback?

Wondering if Coastal Financial at US$75.62 is offering good value right now, or if the recent price action suggests you should be more cautious. The stock has seen a 9.9% decline over the last 7 days and is down 33.3% year to date, despite a 123.6% return over 3 years and 158.9% over 5 years. Recent news coverage has focused on Coastal Financial as a regional bank stock that has already delivered strong multi year returns, which can prompt questions about how much upside is left. At the same...
NYSE:UNM
NYSE:UNMInsurance

Unum Group Leadership Shift At Colonial Life And Valuation Gap To Watch

Unum Group (NYSE:UNM) has appointed Steve Jones as the new president of its Colonial Life business. Jones succeeds Tim Arnold, who is retiring after a 41 year career with the organization. The leadership change comes as Colonial Life reports record earnings and strong business performance. For investors watching NYSE:UNM, this move comes with the stock at $80.38, with a 3 year return of 102.6% and a 5 year return of 212.6%. Recent share performance has also been firm, with the stock up 3.4%...
NYSE:EPAM
NYSE:EPAMIT

Is It Time To Reassess EPAM Systems (EPAM) After Recent Share Price Recovery?

If you are wondering whether EPAM Systems at around US$113.78 offers good value or just more volatility, this article walks through what the current price may be implying about the business. The stock has faced a tough run, with returns of 5.8% over 7 days, 16.0% over 30 days, 43.2% year to date and 28.2% over the last year, and 57.9% and 75.2% over 3 and 5 years respectively. These figures can change how investors think about both risk and potential reward. Recent headlines have focused on...
NYSE:ALL
NYSE:ALLInsurance

Allstate (ALL) Combined Ratio Improvement Tests Bullish Margin Narratives In Q1 2026

Allstate (ALL) has put solid Q1 2026 numbers on the table, with revenue of about US$16.9 billion, basic EPS of US$9.36 and net income of roughly US$2.4 billion setting the tone for this earnings season update. Over the last few quarters, revenue has ranged from about US$16.5 billion in Q1 2025 to US$17.3 billion in Q4 2025, while basic EPS moved from US$2.13 to US$14.55 across the same stretch, giving you a clear view of how the top and bottom lines have tracked. With trailing net profit...
NYSE:W
NYSE:WSpecialty Retail

Wayfair (W) Losses Keep Margins In Focus As Bulls Lean On 45% Earnings Growth Outlook

Wayfair (W) has opened 2026 earnings season with Q1 results that come on the heels of Q4 2025 revenue of US$3.3b and a basic EPS loss of US$0.89, alongside trailing 12 month revenue of US$12.5b and a basic EPS loss of US$2.45. Over the past year, the company has seen quarterly revenue range from US$2.7b to US$3.3b, while basic EPS has moved between a small profit of US$0.12 and losses of up to US$1.02. This sets a clear backdrop of high sales volumes but thin and often negative margins that...